Related Experiment Videos

Enhanced thrombin regulation during warfarin therapy in children compared to adults

P Massicotte1, M Leaker, V Marzinotto

  • 1Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.

Thrombosis and Haemostasis
|November 3, 1998
PubMed

Insights

Warfarin dosing for children may need adjustment. Pediatric patients show different thrombin regulation compared to adults, suggesting potentially safer, less intense warfarin therapy is possible.

Area of Science:

  • Pharmacology
  • Hematology
  • Pediatrics

Background:

  • Current warfarin dosing for pediatric thromboembolic prevention is based on adult guidelines.
  • Optimal warfarin intensity in children remains uncertain, potentially leading to suboptimal treatment.

Purpose of the Study:

  • To compare thrombin regulation ex vivo and in vitro in pediatric and adult patients on warfarin therapy.
  • To investigate potential differences in warfarin's anticoagulant effect between age groups.

Main Methods:

  • Assessed thrombin generation and prothrombin fragment 1.2 levels in plasmas from 40 children and 27 adults on warfarin (INR 2-3).
  • Utilized activated partial thromboplastin time and prothrombin time reagents for thrombin generation assays.
  • Measured plasma concentrations of coagulation factors (II, VII, IX, X) and anticoagulants (protein C, protein S).

Main Results:

  • Children exhibited significantly lower ex vivo prothrombin fragment 1.2 concentrations compared to adults.
  • Thrombin generation was decreased and delayed in children's plasma.
  • Higher complexation of generated thrombin with alpha2-macroglobulin (alpha2M) was observed in children.

Conclusions:

  • Differences in thrombin regulation, potentially due to increased alpha2M, suggest pediatric patients may require different warfarin dosing.
  • Current warfarin therapy intensity in children might be higher than necessary.
  • Clinical trials are warranted to determine optimal, potentially less intense, warfarin treatment for pediatric patients.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...